Operating Lease, Right-of-Use Asset in USD of Aptevo Therapeutics Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aptevo Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Aptevo Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3.96M, a 12.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Aptevo Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $3.96M -$557K -12.3% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $4.11M -$534K -11.5% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $4.25M -$513K -10.8% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $4.39M -$492K -10.1% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $4.52M -$472K -9.46% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $4.65M -$453K -8.89% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $4.77M -$434K -8.35% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $4.88M -$422K -7.96% 31 Dec 2023 10-K 14 Feb 2025
Q3 2023 $4.99M -$416K -7.69% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $5.1M -$414K -7.51% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $5.2M +$3.89M +298% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $5.3M +$3.72M +235% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $5.41M +$3.54M +190% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $5.51M +$3.35M +155% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $1.31M -$1.14M -46.6% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $1.58M -$1.14M -41.8% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $1.87M -$1.13M -37.6% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $2.16M -$1.09M -33.6% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $2.45M -$1.06M -30.2% 31 Mar 2021 10-Q 11 May 2021
Q4 2020 $2.72M -$1.03M -27.4% 31 Dec 2020 10-K 24 Mar 2022
Q3 2020 $2.99M -$991K -24.9% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $3.25M -$1.01M -23.8% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 $3.5M -$977K -21.8% 31 Mar 2020 10-Q 13 May 2020
Q4 2019 $3.75M 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $3.98M 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $4.26M 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 $4.48M 31 Mar 2019 10-Q 09 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.